Targeting ubiquitin specific proteases (USPs) in cancer immunotherapy: from basic research to preclinical application
The effect by targeting inhibition of USP7 on anti-tumor immune response: A Inhibit tumor growth and invasion, and decrease immunosuppressive activity of Treg cells by suppressing the formation of Tip60-mediated Foxp3 dimers that bind to CTLA4 and IL-10 genes, while simultaneously upregulating the expression of IL-2, IFN-γ and TNF‐α genes. B Promote M2 macrophages to polarize to M1 macrophages, increase tumor infiltration of IFN-γ + CD8 + T cells, also upregulate PD-L1 expression. C Inhibit PD-L1 expression and promote p53-dependent apoptosis in tumor cells via p53/MDM2 pathway. D Identify CCDC6 and DNMT1 degradation to enhance the effect of combination PARP-inhibitor and DNA damage inducer RRx-001. E Overcome chemoresistance by combing USP7 inhibitor and cytarabine through downregulating CHK1 protein expression in leukemic, also by combing USP7 inhibitor with anthracycline and taxane through downregulating ABCB1 resistant protein expression in triple negative breast cancer
Publication
Targeting ubiquitin specific proteases (USPs) in cancer immunotherapy: from basic research to preclinical application. (2023) Hongli Gao, et al. J Exp Clin Cancer Res. 2023;42:225. Figure: F1.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | IL-2 | IL-2 | ncbigene_synonym | IL2 | 3558 |
| Homo sapiens | Primates | CTLA4 | CTLA4 | ncbigene_symbol | CTLA4 | 1493 |
| Homo sapiens | Primates | Tip60 | TIP60 | ncbigene_synonym | KAT5 | 10524 |
| Homo sapiens | Primates | IL-10 | IL-10 | ncbigene_synonym | IL10 | 3586 |
| Homo sapiens | Primates | CCDC6 | CCDC6 | ncbigene_symbol | CCDC6 | 8030 |
| Homo sapiens | Primates | Foxp3 | FOXP3 | ncbigene_symbol | FOXP3 | 50943 |
| Homo sapiens | Primates | an | AN | ncbigene_symbol | AN | 100187761 |
| Homo sapiens | Primates | USP7 | USP7 | ncbigene_symbol | USP7 | 7874 |
| Homo sapiens | Primates | DNMT1 | DNMT1 | ncbigene_symbol | DNMT1 | 1786 |
| Homo sapiens | Primates | PD-L1 | PD-L1 | ncbigene_synonym | CD274 | 29126 |
| Homo sapiens | Primates | P53 | P53 | ncbigene_synonym | TP53 | 7157 |
| Homo sapiens | Primates | P53 | P53 | famplex_relations | TP63 | 8626 |
| Homo sapiens | Primates | P53 | P53 | famplex_relations | TP73 | 7161 |
| Homo sapiens | Primates | CHK1 | CHK1 | ncbigene_synonym | CHEK1 | 1111 |
| Homo sapiens | Primates | ABCB1 | ABCB1 | ncbigene_symbol | ABCB1 | 5243 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| HBX19818 | NA | mesh:C546441 | ||
| GNE-6776 | NA | mesh:C582059 | ||
| cytarabine | Cytarabine | mesh:D003561 | cytarabine | chebi:28680 |
| anthracycline | anthracycline | mesh:D018943 | Anthracyclines | chebi:48120 |
| taxane | taxane | mesh:C080625 | taxane | chebi:36064 |
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|---|---|---|---|
| tumor | NA | mesh:D009369 | ||
| cytotoxicity | NA | mesh:D064420 |